Literature DB >> 1968043

Human arylsulfatase B: MOPAC cloning, nucleotide sequence of a full-length cDNA, and regions of amino acid identity with arylsulfatases A and C.

E H Schuchman1, C E Jackson, R J Desnick.   

Abstract

cDNAs encoding the human lysosomal hydrolase, arylsulfatase B (ASB; N-acetylgalactosamine-4-sulfatase, EC 3.1.6.1), were isolated from a hepatoma cell cDNA library using an ASB-specific oligonucleotide generated by the MOPAC (mixed oligonucleotide primed amplification of cDNA) technique. To facilitate cDNA cloning, human ASB was purified to apparent homogeneity and a total of 112 amino acid residues were microsequenced from the N-terminus and four internal tryptic peptides of the 47-kDa subunit. Based on the ASB N-terminal amino acid sequence, two oligonucleotide mixtures containing inosines to reduce the mixture complexity were constructed and used as primers to amplify an ASB-specific product from human placental cDNA by the polymerase chain reaction. DNA sequencing of this MOPAC product demonstrated colinearity with 21 N-terminal ASB amino acids. Based on this sequence and on codon usage for the adjacent conserved amino acids in human arylsulfatases A and C, a unique 66-mer was synthesized and used to screen a human hepatoma cell cDNA library. Four putative positive cDNA clones were isolated, and the largest insert (pASB-1) was sequenced in both orientations. The 1834-bp pASB-1 insert had a 1278-bp open reading frame encoding 425 amino acids that was colinear with 85 microsequenced amino acids of the purified enzyme, demonstrating its authenticity. Using the pASB-1 cDNA as a probe, a full-length cDNA clone, pASB-4, was isolated from a human testes library and sequenced in both orientations. pASB-4 had a 2811-bp insert containing a 559-bp 5' untranslated sequence, a 1602-bp open reading frame encoding 533 amino acids (six potential N-glycosylation sites), a 641-bp 3' untranslated sequence, and a 9-bp poly(A) tract. Comparison of the predicted amino acid sequences of arylsulfatases A, B, and C revealed regions of identity, particularly in their N-termini.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1968043     DOI: 10.1016/0888-7543(90)90460-c

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  17 in total

1.  Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients.

Authors:  T Litjens; D A Brooks; C Peters; G J Gibson; J J Hopwood
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

2.  Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients.

Authors:  M F G Petry; K Nonemacher; J C Sebben; I V D Schwartz; A C M Azevedo; M G Burin; A R de Rezende; C A Kim; R Giugliani; S Leistner-Segal
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

3.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

4.  Enzyme replacement therapy in a feline model of Maroteaux-Lamy syndrome.

Authors:  A C Crawley; D A Brooks; V J Muller; B A Petersen; E L Isaac; J Bielicki; B M King; C D Boulter; A J Moore; N L Fazzalari; D S Anson; S Byers; J J Hopwood
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

5.  Mucopolysaccharidosis type VI: identification of three mutations in the arylsulfatase B gene of patients with the severe and mild phenotypes provides molecular evidence for genetic heterogeneity.

Authors:  W D Jin; C E Jackson; R J Desnick; E H Schuchman
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

6.  Targeted disruption of the arylsulfatase B gene results in mice resembling the phenotype of mucopolysaccharidosis VI.

Authors:  M Evers; P Saftig; P Schmidt; A Hafner; D B McLoghlin; W Schmahl; B Hess; K von Figura; C Peters
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

7.  Analysis of N-acetylgalactosamine-4-sulfatase protein and kinetics in mucopolysaccharidosis type VI patients.

Authors:  D A Brooks; P A McCourt; G J Gibson; L J Ashton; M Shutter; J J Hopwood
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

8.  Identification of point mutations in the steroid sulfatase gene of three patients with X-linked ichthyosis.

Authors:  E Basler; M Grompe; G Parenti; J Yates; A Ballabio
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

9.  Attempted enzyme replacement using human amnion membrane implantations in mucopolysaccharidoses.

Authors:  J Muenzer; E F Neufeld; G Constantopoulos; R C Caruso; M I Kaiser-Kupfer; A Pikus; J Danoff; R R Berry; H D McDonald; J N Thompson
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

10.  Arylsulfatase B-deficient mucopolysaccharidosis in rats.

Authors:  M Yoshida; J Noguchi; H Ikadai; M Takahashi; S Nagase
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.